Format

Send to

Choose Destination
BMJ Case Rep. 2018 Apr 21;2018. pii: bcr-2018-224764. doi: 10.1136/bcr-2018-224764.

Pneumocystis jiroveci pneumonia in a patient taking Benepali for rheumatoid arthritis.

Author information

1
Rheumatology, Glasgow Royal Infirmary, Glasgow, UK.

Abstract

We present a case of a 57-year-old woman who contracted Pneumocystis jiroveci pneumonia while on Benepali, the biosimilar version of etanercept for rheumatoid arthritis. She had seropositive erosive disease. She was admitted to clinic with a 2-week history of dyspnoea, dry cough and fever. Her initial examination showed her to be hypoxic on air with saturations of 77% and left basal crackles. Her admission chest X-ray showed fine reticular shadowing, with an initial suspicion of pulmonary fibrosis. She was empirically treated for community-acquired pneumonia but continued to deteriorate with a worsening type 1 respiratory failure. She was intubated and ventilated on intensive care. The suspicion was raised of P. jiroveci pneumonia given her immunosuppression, hypoxic presentation and chest X-ray changes. This was confirmed on sputum PCR. She was treated with a 3-week course of steroids and co-trimoxazole. She was discharged home after a 2-week admission.

KEYWORDS:

biological agents; drugs: musculoskeletal and joint diseases; infections; musculoskeletal and joint disorders; rheumatoid arthritis

PMID:
29680792
DOI:
10.1136/bcr-2018-224764
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center